Omnicell receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Omnicell Inc (OMCL)
Omnicell Inc stock price live, this page displays NASDAQ OMCL stock exchange data. View the OMCL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Omnicell Inc real time stock price chart below.
What Is the Omnicell Inc Stock Price Today?
The Omnicell Inc stock price today is 41.10.
What Is the Stock Symbol for Omnicell Inc?
The stock symbol for Omnicell Inc is "OMCL."
What Stock Exchange Does Omnicell Inc Trade On?
Omnicell Inc is listed and trades on the NASDAQ stock exchange.
Is Omnicell Inc a Good Stock to Buy?
Determining whether Omnicell Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OMCL quote. (ISIN: US68213N1090)
What Is the Omnicell Inc Stock Price Today?
The Omnicell Inc stock price today is 41.10.
What Is the Stock Symbol for Omnicell Inc?
The stock symbol for Omnicell Inc is "OMCL."
What Stock Exchange Does Omnicell Inc Trade On?
Omnicell Inc is listed and trades on the NASDAQ stock exchange.
Is Omnicell Inc a Good Stock to Buy?
Determining whether Omnicell Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OMCL quote. (ISIN: US68213N1090)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.91
41.85
52 wk Range
22.66
55.00
OMCL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.9141.85
52 wk Range
22.6655.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OMCL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
57.43
Upside
+39.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
- Omnicell receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Omnicell Inc For: 5 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Omnicell Inc Company Profile
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Omnicell Inc SWOT Analysis
Financial Rebound | Omnicell surpasses Q2 expectations, raising full-year guidance and sparking investor confidence amid improving hospital capital expenditure trends |
Strategic Evolution | Explore Omnicell's expansion into specialty pharmacy and the potential impact on Advanced Services revenue streams in a rapidly growing market segment |
Operational Overhaul | New COO appointment signals focus on cost reduction and operational efficiency, potentially driving long-term profitability and market competitiveness |
Market Positioning | Analysts set price targets ranging from $39 to $58, reflecting varied outlooks on Omnicell's ability to navigate industry challenges and capitalize on healthcare tech trends |
Omnicell Inc Earnings Call Summary for Q4/2025
- Omnicell's Q4 2025 EPS of $0.40 missed forecasts by 20%, while revenue reached $314 million, slightly exceeding expectations, causing shares to plummet 14.69% in pre-market trading.
- Full-year 2025 revenue increased 6.6% to $1.185 billion, with service revenue growing 8% while product revenue declined 1%, indicating a shift toward recurring revenue streams.
- CEO Randall Lipps emphasized strategic focus on sustainable, higher-margin business models with recurring revenues and cloud-based enterprise solutions.
- For 2026, Omnicell projects revenue between $1.215-1.255 billion and non-GAAP EPS of $1.65-1.85, with plans to launch the Titan XT platform in H2 2026.
- Cash and equivalents fell to $197 million from $369 million in 2024, while the company faces challenges from supply chain disruptions and increased competition in healthcare technology.
Last Updated: 02/05/2026, 11:02 PM
Read Full TranscriptCompare OMCL to Peers and Sector
Metrics to compare | OMCL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOMCLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 910.0x | 27.0x | −0.5x | |
PEG Ratio | −10.68 | 0.14 | 0.00 | |
Price/Book | 1.5x | 4.3x | 2.6x | |
Price / LTM Sales | 1.6x | 4.2x | 3.3x | |
Upside (Analyst Target) | 41.1% | 3.9% | 45.5% | |
Fair Value Upside | Unlock | 18.0% | 5.7% | Unlock |
Analyst Ratings
7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 57.43
(+39.73% Upside)
Earnings
Latest Release
Feb 05, 2026
EPS / Forecast
0.40 / 0.50
Revenue / Forecast
314.00M / 313.39M
People Also Watch
FAQ
What Is the Omnicell (OMCL) Stock Price Today?
The Omnicell stock price today is 41.10 USD.
What Stock Exchange Does Omnicell Trade On?
Omnicell is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Omnicell?
The stock symbol for Omnicell is "OMCL."
What Is the Omnicell Market Cap?
As of today, Omnicell market cap is 1.87B USD.
What Is Omnicell's Earnings Per Share (TTM)?
The Omnicell EPS (TTM) is 0.05.
When Is the Next Omnicell Earnings Date?
Omnicell will release its next earnings report on Apr 23, 2026.
From a Technical Analysis Perspective, Is OMCL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Omnicell Stock Split?
Omnicell has split 0 times.
How Many Employees Does Omnicell Have?
Omnicell has 3600 employees.
What is the current trading status of Omnicell (OMCL)?
As of Mar 02, 2026, Omnicell (OMCL) is trading at a price of 41.10 USD, with a previous close of 41.10 USD. The stock has fluctuated within a day range of 40.91 USD to 41.85 USD, while its 52-week range spans from 22.66 USD to 55.00 USD.
What Is Omnicell (OMCL) Price Target According to Analysts?
The average 12-month price target for Omnicell is 57.43 USD, with a high estimate of 70 USD and a low estimate of 49 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +39.73% Upside potential.
What Is the OMCL Premarket Price?
OMCL's last pre-market stock price is 41.29 USD. The pre-market share volume is 420.00, and the stock has decreased by 0.19, or 0.46%.
What Is the OMCL After Hours Price?
OMCL's last after hours stock price is 40.70 USD, the stock has decreased by -0.40, or -0.97%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.